What is Neurocrine (NBIX)?
Neurocrine Biosciences is a biopharmaceutical company specializing in the development and commercialization of treatments for neurological and endocrine-related disorders. The company focuses on diseases such as movement disorders, psychiatric conditions, and hormonal imbalances. Neurocrine's research and development efforts emphasize innovative therapies that address unmet medical needs through novel mechanisms of action. The company collaborates with academic institutions, biotechnology firms, and pharmaceutical companies to advance its pipeline. Its portfolio includes approved products as well as investigational compounds in various stages of clinical trials. Neurocrine operates with a commitment to scientific rigor and regulatory compliance, aiming to improve patient outcomes through targeted therapeutic solutions.
Neurocrine Stock Price Today: Live Overview
The price today is shaped by active trading, Neurocrine trades at $129.91. The intraday low and high range from $127.15 to $129.95, with a daily change of 0%.
FAQ: Neurocrine (NBIX)
What is the current price of NBIX stock?
The stock is currently priced at $129.91.
Does NBIX pay dividends?
Neurocrine does not pay dividends.
Does NBIX have a formal corporate presence or regional headquarters in the UAE?
Neurocrine operates in the UAE only through partners and distributors without a direct regional office.
What is NBIX best known for?
Neurocrine is most famous for its development of treatments for neurological and endocrine diseases.
What assets are typically shown together with NBIX?
Commonly shown alongside NBIX: Genus, Incyte, Alector, Inc.
Latest shares articles



